HMGN1P7

Across TCGA pan-cancer cohorts, HMGN1P7 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated HMGN1P7 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher HMGN1P7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated HMGN1P7 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LIHC show a favorable association.

CHOL, BLCA, and PAAD are the cancer types where HMGN1P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	III,IV	0.162	0.915	.004	44	view →
BLCA	OS	Median	IV	0.313	0.670	.003	41	view →
PAAD	OS	Tertile	All	0.365	0.646	<.001	29	view →
HNSC	OS	Tertile	All	0.815	0.699	.004	20	view →
LIHC	OS	Tertile	All	0.896	0.626	.026	15	view →
LUAD	DFS	Median	IV	0.503	0.817	.018	14	view →
READ	OS	Median	II,III,IV	0.959	0.864	.019	9	view →
DLBC	DFS	Tertile	II,III,IV	0.373	0.836	.027	9	view →
LAML	DFS	Quartile	All	0.659	0.428	.024	8	view →
PCPG	DFS	Tertile	All	1.000	0.732	.015	8	view →
OV	DFS	Median	IV	0.226	0.406	.015	6	view →
BRCA	DFS	Median	III,IV	0.746	0.840	.035	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

HMGN1P7–CHOL (OS)

Open the CHOL breakdown →